These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 22304236)

  • 21. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERĪ± as anti-breast cancer agents.
    Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor agents 287. Substituted 4-amino-2H-pyran-2-one (APO) analogs reveal a new scaffold from neo-tanshinlactone with in vitro anticancer activity.
    Dong Y; Nakagawa-Goto K; Lai CY; Morris-Natschke SL; Bastow KF; Lee KH
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2341-4. PubMed ID: 21420855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and biological evaluation of novel 7H-benzo [c] [1, 3] dioxolo [4, 5-f] chromen-7-one derivatives with potential anti-tumor activity.
    Zhou S; Huang G
    Bioorg Chem; 2020 Dec; 105():104381. PubMed ID: 33113412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-AIDS agents 79. Design, synthesis, molecular modeling and structure-activity relationships of novel dicamphanoyl-2',2'-dimethyldihydropyranochromone (DCP) analogs as potent anti-HIV agents.
    Zhou T; Shi Q; Chen CH; Zhu H; Huang L; Ho P; Lee KH
    Bioorg Med Chem; 2010 Sep; 18(18):6678-89. PubMed ID: 20728367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor agents 278. 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs as potent in vitro anti-cancer agents.
    Dong Y; Nakagawa-Goto K; Lai CY; Morris-Natschke SL; Bastow KF; Lee KH
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4085-7. PubMed ID: 20542429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor agents. 272. Structure-activity relationships and in vivo selective anti-breast cancer activity of novel neo-tanshinlactone analogues.
    Dong Y; Shi Q; Pai HC; Peng CY; Pan SL; Teng CM; Nakagawa-Goto K; Yu D; Liu YN; Wu PC; Bastow KF; Morris-Natschke SL; Brossi A; Lang JY; Hsu JL; Hung MC; Lee EY; Lee KH
    J Med Chem; 2010 Mar; 53(5):2299-308. PubMed ID: 20148565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immobilization of gossypol derivative on N-polyvinylpyrrolidone increases its water solubility and modifies membrane-active properties.
    Ionov M; Gordiyenko N; Olchowik E; Baram N; Zijaev K; Salakhutdinov B; Bryszewska M; Zamaraeva M
    J Med Chem; 2009 Jul; 52(14):4119-25. PubMed ID: 19603832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.
    Shafee N; Smith CR; Wei S; Kim Y; Mills GB; Hortobagyi GN; Stanbridge EJ; Lee EY
    Cancer Res; 2008 May; 68(9):3243-50. PubMed ID: 18451150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
    Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
    J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist.
    Poole AJ; Li Y; Kim Y; Lin SC; Lee WH; Lee EY
    Science; 2006 Dec; 314(5804):1467-70. PubMed ID: 17138902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility.
    Kim IH; Heirtzler FR; Morisseau C; Nishi K; Tsai HJ; Hammock BD
    J Med Chem; 2005 May; 48(10):3621-9. PubMed ID: 15887969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral drug-induced nephrotoxicity.
    Izzedine H; Launay-Vacher V; Deray G
    Am J Kidney Dis; 2005 May; 45(5):804-17. PubMed ID: 15861345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor Agents. 239. Isolation, structure elucidation, total synthesis, and anti-breast cancer activity of neo-tanshinlactone from Salvia miltiorrhiza.
    Wang X; Bastow KF; Sun CM; Lin YL; Yu HJ; Don MJ; Wu TS; Nakamura S; Lee KH
    J Med Chem; 2004 Nov; 47(23):5816-9. PubMed ID: 15509181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme.
    Fernandes-Alnemri T; Litwack G; Alnemri ES
    J Biol Chem; 1994 Dec; 269(49):30761-4. PubMed ID: 7983002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.
    Nicholson DW; Ali A; Thornberry NA; Vaillancourt JP; Ding CK; Gallant M; Gareau Y; Griffin PR; Labelle M; Lazebnik YA
    Nature; 1995 Jul; 376(6535):37-43. PubMed ID: 7596430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug absorption in the gut.
    Orme M
    Br J Anaesth; 1984 Jan; 56(1):59-67. PubMed ID: 6362692
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmaceutical salts.
    Berge SM; Bighley LD; Monkhouse DC
    J Pharm Sci; 1977 Jan; 66(1):1-19. PubMed ID: 833720
    [No Abstract]   [Full Text] [Related]  

  • 38. Antitumor agents. 289. Design, synthesis, and anti-breast cancer activity in vivo of 4-amino-2H-benzo[h]chromen-2-one and 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one analogues with improved water solubility.
    Dong Y; Nakagawa-Goto K; Lai CY; Morris-Natschke SL; Bastow KF; Kim Y; Lee EY; Lee KH
    J Nat Prod; 2012 Mar; 75(3):370-7. PubMed ID: 22304236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.